Regulatory efforts to address the access gap for foreign new drugs in China: the priority review program and related policies.

Glob Health Res Policy · 2025 · PMC11853587 · PMID 40001257

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

The time trend of launch delay was depicted in Figure 1 , presenting an overall trend of stabilization for the pre-PR approvals.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.